China NMPA Product Recall - Neuromuscular conduction cables in patient monitors

Philips (China) Investment Co., Ltd. initiated a voluntary Class II recall of specific neuromuscular conduction patient monitor cables. Publicized by the National Medical Products Administration (NMPA) on June 19, 2017, this action addresses a critical product defect. The core issue involves a local insulation defect within the accelerometer housing of the affected cables. This flaw has the potential to generate an unexpected electrical current between the accelerometer housing, typically positioned on a patient's thumb, and the corresponding stimulation electrode. Such an event could lead to localized heating for the patient during monitoring. Under the NMPA's regulatory oversight, Philips (China) is actively recalling these cables, which are registered under specific numbers and intended for use with their patient monitors. The company is required to furnish comprehensive details regarding affected product models, specifications, and batch numbers via a Medical Device Recall Event Report Form. This proactive recall demonstrates adherence to medical device regulations and a commitment to patient safety, aiming to prevent potential patient harm.